Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2003
09/04/2003US20030166887 Diagnosis, therapy of bone disorders; modulation cell differentiation
09/04/2003US20030166876 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3
09/04/2003US20030166875 Fibroblast growth factor homologous factor-2 and methods of use
09/04/2003US20030166873 Endothelial growth factor; measuring binding to monoclonal antibodies; calibration
09/04/2003US20030166867 Fibrin nanoparticles and uses thereof
09/04/2003US20030166862 Purified mammalian CTLA-8 antigens and related reagents
09/04/2003US20030166861 Human blue-light photoreceptor hCRY2
09/04/2003US20030166857 Genes for receptor tyrosine kinases and their cognate ligands, their insertion into genetic engineered DNA vectors; useful in the diagnosis and treatment of neoplastic diseases
09/04/2003US20030166854 Allelic variant of human STAT3
09/04/2003US20030166853 Mucin peptide with immunoenhancing properties
09/04/2003US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound
09/04/2003US20030166849 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
09/04/2003US20030166848 Polypeptides having specific amino acid sequence lacking its associated signal peptide; a chimeric polypeptide fused to a heterologous polypeptide which is an epitope tag or an Fc region of an immunoglobulin
09/04/2003US20030166847 Novel human leptin receptor gene-related protein
09/04/2003US20030166844 Immunologenic polypeptides; therapy for Streptococcus infections
09/04/2003US20030166838 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives
09/04/2003US20030166837 Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof
09/04/2003US20030166832 Methods and compositions for impairing multiplication of HIV-1
09/04/2003US20030166588 Splice-region antisense composition and method
09/04/2003US20030166587 Compounds and methods for modulating activation of NF-kB
09/04/2003US20030166559 Comprises tumor necrosis factor antagonist activity for treatment of autoimmune conditions
09/04/2003US20030166543 Functional antagonists of hedgehog activity
09/04/2003US20030166541 Novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins.
09/04/2003US20030166540 Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY30
09/04/2003US20030166533 Genes for male accessory gland proteins in Drosophila melanogaster
09/04/2003US20030166532 Annexin V, is used to prevent thrombosis without increasing hemorrhage. Annexin binds to phosphatidylserine on the outer surface of cell membranes, thereby preventing binding of the prothrombinase complex necessary for thrombus formation.
09/04/2003US20030166527 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs.
09/04/2003US20030166300 Growth-related inflammatory and immune response protein
09/04/2003US20030166288 Altering Ku80 levels in plants; recobinant expression cassettes
09/04/2003US20030166285 Methods and compositions for genetically modifying primate bone marrow cells
09/04/2003US20030166282 Forming a double stranded RNAs, has a replication sequence that is identical to a selected target gene; gene therapy
09/04/2003US20030166280 Drug deliverying a complex wherein the zeta potential is not positive, expressing nucleic acids in cells
09/04/2003US20030166279 Minicell-based transfection
09/04/2003US20030166278 Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
09/04/2003US20030166276 High speed cell proliferating, cell differentiation of central nervous system cells in a medium comprising carbohydrates, buffer, hormones, growth factor stimulates; transplanting for damage tissue
09/04/2003US20030166275 Preparation of erythropoietin by endogenous gene activation
09/04/2003US20030166274 Three-dimensional matrix for producing living tissue equivalents
09/04/2003US20030166273 Culturing in a medium containing vascular endothelial cell growth factor, fibroblast growth factor, insulin-like growth factor and epidermal growth factor; inducing blood vessel formation when transplanted in vivo
09/04/2003US20030166272 Contacting a committed cell with an antibody to retrodifferentiate; therapeutic treatment of an immunological disorder or disease; stem cells
09/04/2003US20030166271 Supporting cell differentiation in culture with a genetical modified cells; use for gene therapy
09/04/2003US20030166270 Cell culturing with a mutant modified cyclin dependent kinase protein, screening cancer-causing agents
09/04/2003US20030166255 Culturing a host cell for expressing a first recombinant protein isoprenoid synthase and a second recombinant protein cytochromes, for transforming a disease resistance plants; genetic engineering
09/04/2003US20030166253 A simple and efficient method of producing mammalian reovirus is developed using HEK 293 cells. The method provides for fast production of reovirus in high yield. Furthermore, this method provides for a simpler purification procedure of the
09/04/2003US20030166247 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures
09/04/2003US20030166239 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques
09/04/2003US20030166238 Recombinant toxin fragments
09/04/2003US20030166235 Enzyme inhibitors; immunoassay
09/04/2003US20030166228 Anti-interferon-alpha antibodies
09/04/2003US20030166227 Comprises polypeptides having exonuclease domains in plants; homologous recombination
09/04/2003US20030166221 Megakaryocyte tyrosine kinases; signal transduction in hematopoietic cells
09/04/2003US20030166219 Mitogen-activated protein/extracellular signal-regulated kinases (MAP/ERK)
09/04/2003US20030166210 Polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for the treatment of cognitive and
09/04/2003US20030166189 Peptide of given amino acid sequence; sulfotransferases; useful in labeling agents with tagged sulfur, diagnosis/treatment of cancer, hypertension, renal and neurodegenerative diseases
09/04/2003US20030166187 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
09/04/2003US20030166174 Fermenting amino acids using lysine resistant methanobacterium for animal feeds, foodstuffs and drug design
09/04/2003US20030166165 Comprises nucleotide sequences coding polyene macrolide antibiotics for use in veterinary medicine
09/04/2003US20030166164 IL-17 like molecules and uses thereof
09/04/2003US20030166155 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/04/2003US20030166154 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
09/04/2003US20030166153 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/04/2003US20030166151 Comprises peptides of ionotropic glutamate receptor for diagnosing and treating nervous system disorders; drug screening
09/04/2003US20030166147 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
09/04/2003US20030166146 Genetically engineered tissue for treating neurodegenerative diseases and bovine spongiform encephalopathy (BSE)
09/04/2003US20030166141 Regulation of endogenous gene expression in cells using zinc finger proteins
09/04/2003US20030166140 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide polyadenylation sequence all
09/04/2003US20030166137 Mammalian sweet and amino acid heterodimeric taste receptors
09/04/2003US20030166132 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166102 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166101 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166100 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166098 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166097 Comprises nucleotide sequences coding membrane proteins for use diagnosing, treating and preventing autoimmune, inflammatory, viral, infectious and cancer diseases
09/04/2003US20030166096 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166095 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166094 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166093 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166092 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166091 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166090 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166089 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166088 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166087 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166086 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166085 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166084 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166083 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166082 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166081 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166080 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166078 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166077 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166076 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166075 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166074 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166073 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
09/04/2003US20030166071 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166061 14273 receptor, a novel G-protein coupled receptor
09/04/2003US20030166051 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166045 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant
09/04/2003US20030166041 Nucleotide sequences coding tim mitochondrial protein (TRP) which comprises zinc finger membrane protein for treating, diagnosing and preventing cancer and neurodegenerative diseases